Constipation in Cancer Patients – Causes, Prevention and Treatment Methods
In this article
Constipation in cancer patients: causes, prevention and treatment
Constipation is one of cancer patients' most common but least discussed problems. According to European Society for Medical Oncology (ESMO) guidelines, %40-90 of patients with advanced cancer experience constipation, while among people taking opioid painkillers, %40-60 develop drug-induced constipation. Constipation is more than uncomfortable: it causes abdominal pain, nausea, loss of appetite, impaired quality of life and sometimes discontinuation of pain treatment. The good news is that most constipation can be prevented and treated. This article explains its causes in cancer patients, prevention, medication options and situations requiring prompt medical attention, in light of current guidelines.
- Definition: Fewer than three bowel movements weekly, straining, hard or lumpy stools (Bristol type 1-2), and incomplete evacuation. In cancer patients, changes from personal habits matter more than frequency.
- Most common causes: Opioid painkillers, certain nausea medications (such as ondansetron), certain chemotherapies (such as vincristine and thalidomide), low food and fluid intake, inactivity and metabolic problems such as high calcium.
- Prevention: When starting an opioid painkiller, a laxative should generally be started simultaneously unless contraindicated; the body does not adapt to opioid constipation.
- Medications: First choices are osmotic (macrogol, lactulose) and/or stimulant (senna, sodium picosulfate, bisacodyl) laxatives. Fiber-increasing (bulk-forming) drugs are not recommended for opioid constipation or patients with low fluid intake.
- Myth: Current evidence has not shown that modern stimulant laxatives make the bowel "lazy".
- Emergency: Seek care immediately for severe abdominal pain, vomiting, inability to pass gas, leg weakness or inability to urinate.
- Rewritten according to the ESMO constipation guideline and United States gastroenterology societies' chronic constipation (2023) and opioid-induced constipation (2019) guidelines.
- Added opioid-induced constipation, effects of nausea medications and chemotherapies, the Bristol stool scale and a stepwise treatment diagram.
- Corrected laxative groups and reclassified them with example products from Türkiye; examined the belief that "laxatives make the bowel lazy" using current evidence.
- Expanded criteria for seeking care; added emergencies such as spinal cord compression and bowel obstruction.
What Is Constipation?
According to international Rome IV criteria, constipation involves fewer than three weekly spontaneous bowel movements together with at least two symptoms such as straining in more than a quarter of bowel movements, lumpy or hard stools, incomplete evacuation, a feeling of anal blockage or needing manual assistance. Opioid-induced constipation is constipation that is new or worsening when an opioid painkiller is started or its dose changed or increased.
In cancer patients, change from personal bowel habits matters more than weekly frequency. Someone normally going daily who has not gone for three days may have a more meaningful change than someone normally going three times weekly who misses two days. To describe stool consistency, doctors use the Bristol stool scale as an assessment tool.
Figure 1 · Bristol Stool Scale
Stool shape gives an indication of intestinal transit speed.
Causes of Constipation in Cancer Patients
Constipation in cancer patients generally has multiple causes rather than just one. The table below summarizes causes listed by ESMO and the United States National Cancer Institute (NCI):
| Cause group | Examples |
|---|---|
| Opioid painkillers | Morphine, oxycodone, fentanyl, tramadol, codeine. They slow bowel movements; unlike nausea, this does not resolve over time. |
| Nausea medications | Ondansetron and granisetron, 5-HT3 antagonists, slow transit through the large bowel. They commonly cause constipation on chemotherapy days. |
| Chemotherapy and other cancer drugs | Vincristine, vinblastine, vinorelbine (dose-dependent, through nerve damage); thalidomide (one of its most common side effects); oxaliplatin and taxanes (by affecting nerves controlling the bowel). |
| Other medications | Iron and calcium medications, stomach medications containing aluminum or calcium, diuretics, certain antidepressants and anticholinergic drugs. |
| Metabolic causes | Fluid loss (dehydration), high calcium (hypercalcemia), low potassium, kidney failure (uremia). |
| The disease itself | Pressure on the bowel from abdominal or pelvic tumors, peritoneal spread, radiation-related bowel narrowing, spinal cord compression. |
| General condition | Low food and fluid intake, inactivity, being bedridden, lack of toilet privacy, depression. |
We explained constipation caused by opioid painkillers in detail in our opioid-induced constipation article. Stopping painkillers for fear of constipation is inappropriate; we discuss cancer pain treatment in how cancer pain is treated and concerns about addiction in do painkillers cause addiction . Information on nausea medication use is in chemotherapy-related nausea and vomiting our article on this topic.
Prevention: Before Constipation Begins
Treating constipation after it develops is harder than preventing it. The most important rule is: When an opioid painkiller is started, a regular laxative should be started the same day unless contraindicated. ESMO explicitly recommends this. Other measures:
- Fluids: Unless your doctor recommends fluid restriction, drink approximately 8 glasses of water or clear fluids daily. Hot drinks and prune juice stimulate bowel activity in some people.
- Fiber, but cautiously: Vegetables, fruit and whole grains help people who can drink adequately and remain active. But suddenly increasing fiber can worsen constipation and bloating in people with low intake, those bedridden or with advanced disease. Discuss fiber intake with your doctor or dietitian. Dietary advice is available in dietary recommendations for constipation our article on this topic.
- Movement: Walk as your strength permits. If unable to walk, even gentle exercises in bed or a chair, such as leg movements and abdominal muscle tensing and relaxing, help.
- Toilet routine: The bowels are more active after meals, particularly breakfast. Try sitting on the toilet at the same time daily and do not postpone the urge.
- Correct position: Place a small stool under your feet to raise knees above hips; lean forward slightly. If possible, use a toilet or commode rather than a bedpan.
- Privacy: Being able to use the toilet comfortably and without rushing matters at home or in hospital.
- Keep records: Noting bowel movement days and Bristol types helps when talking with your doctor.
Constipation Medications: Which and When?
Constipation drugs (laxatives) work in different ways. The table below shows groups, example products available in Türkiye and precautions. We also explain their general features in what is a laxative our article on this subject.
| Group | How does it work? | Examples in Türkiye | Caution |
|---|---|---|---|
| Osmotic: macrogol (PEG) | Retains water in the bowel to soften stool | Limited products licensed for constipation; ask a pharmacy | first choice Well tolerated |
| Osmotic: lactulose | Draws water into the bowel | Duphalac, Laevolac, Osmolak and other syrups | Starts working in 2-3 days; sweet taste, bloating and gas are common |
| Osmotic: magnesium salts | Draws water into the bowel | Magnesium-containing products; ask a pharmacy | Magnesium may accumulate in kidney failure |
| Stimulant: senna | Increases bowel movements | X-M, Bekunis, Laxeno, Sennotab | first choice May cause cramps; generally taken in the evening |
| Stimulant: sodium picosulfate | Increases bowel movements | Dulcolax (contains picosulfate in Türkiye), Laxapico, Piksatif, Lactosoft | Cramps; not used in bowel obstruction |
| Stimulant: bisacodyl | Increases bowel movements | Bisakol coated tablets, Supolaks suppositories | Suppositories act quickly if the rectum is full |
| Bulk-forming: psyllium (plantain seed) | Retains water and increases stool bulk | Generally sold as a supplement | caution Not recommended for opioid constipation or low fluid intake; may worsen obstruction |
| Lubricant: liquid paraffin | Lubricates stool | Products containing liquid paraffin | caution May enter the lungs and cause pneumonia with swallowing difficulty or bed confinement; reduces absorption of vitamins A, D, E, K |
| Rectal: suppositories and enemas | Directly empties the rectum | Glycerin suppositories, Supolaks suppositories, Fleet Enema, B.T. Enema | Bleeding and infection risk with low white blood cells or platelets; do not use unless recommended by a doctor |
| Opioid-specific: PAMORA | Blocks opioid effects in the bowel without impairing pain relief | Methylnaltrexone, naloxegol, naldemedine; limited access in Türkiye | For opioid constipation unresponsive to laxatives; not used in bowel obstruction |
Product examples in Türkiye come from medication information websites and are not a complete list; consult your doctor or pharmacist for product choice and dosage. Other drugs such as prucalopride (Resolor) may be used in certain situations.
ESMO guidelines recommend osmotic and/or stimulant laxatives first for cancer patients; both groups may be combined if one is insufficient. The American gastroenterology societies' (ACG and AGA) 2023 chronic constipation guideline also strongly supports macrogol and short-term or rescue bisacodyl and sodium picosulfate; it conditionally recommends senna and magnesium oxide.
This is a widespread belief. Permanent bowel damage ("cathartic colon") was described historically with prolonged use of older, strong stimulant laxatives. A comprehensive review published in 2024 describes this as a historical condition not expected with modern laxatives , stating that stimulant laxative harms have probably been exaggerated and there is no convincing evidence of an association with colorectal cancer. Bowel wall discoloration (melanosis coli) sometimes seen with senna is harmless and reversible. Some patient sources nevertheless continue warning that long-term use may be habit-forming. For cancer patients, the main risk is leaving constipation untreated.
Figure 2 · Stepwise Constipation Treatment
Begins with prevention; response is evaluated at each step.
Special Medications for Opioid-Induced Constipation
For opioid constipation not relieved by laxatives, drugs selectively blocking opioid effects in the bowel from the PAMORA group (methylnaltrexone, naloxegol, naldemedine) may be used. Because they do not enter the brain, they do not reduce pain relief. ESMO and the American Gastroenterological Association (AGA) recommend them for opioid constipation unresponsive to laxatives; ESMO also lists combination oxycodone-naloxone products as options. We could not verify licensing and access in Türkiye; if needed, the doctor managing your pain will assess alternatives. Sometimes changing the opioid type can also reduce constipation.
When Should You Seek Medical Care?
Most constipation improves with home measures and doctor-recommended laxatives. However, in cancer patients it may sometimes be a sign of a more serious condition : bowel obstruction, hardened stool lodged in the bowel (fecal impaction), high calcium or spinal cord compression. NCI warns that fecal impaction may be life-threatening.
Figure 3 · Warning Signs in Constipation
Some accompanying symptoms require urgent assessment.
- When blood counts are low, particularly white blood cells or platelets, suppositories, enemas or rectal thermometers must not be used because of bleeding and infection risk.
- Nausea medicines can cause constipation; discuss planning laxatives in advance for chemotherapy days with your doctor.
- Severe constipation and abdominal pain with drugs such as vincristine may indicate bowel paralysis (paralytic ileus); report this immediately.
- Common laxatives: Lactulose syrups (Duphalac and similar products), senna products (X-M, Bekunis, Laxeno, Sennotab), sodium picosulfate (Dulcolax, Laxapico, Piksatif), bisacodyl (Bisakol coated tablets, Supolaks suppositories) and enemas (Fleet Enema, B.T. Enema) are available.
- Caution: Dulcolax in Türkiye, unlike bisacodyl-containing products abroad, sodium picosulfate contains this ingredient.
- Macrogol: Options for macrogol products licensed for constipation are limited; some are licensed only for colonoscopy preparation.
- PAMORA drugs: We could not confirm that methylnaltrexone, naloxegol and naldemedine are marketed in Türkiye.
- Palliative care support is important for addressing constipation, pain and nutritional problems together in cancer patients; we discussed inadequate access to this service in this article previously.
Frequently Asked Questions
- I Take Morphine; Will Constipation Improve Over Time?
- No. Opioid-related nausea and drowsiness generally decrease within days, but the body does not adapt to constipation. Therefore, laxatives should be used regularly for as long as opioids are taken.
- Do I Need a Bowel Movement Every Day?
- No. What matters is preserving your normal pattern and passing soft stools without straining. Generally, no bowel movement for 3 days or longer is a reason to notify your doctor.
- Is a High-Fiber Diet Always Good?
- Yes, for people who can drink enough and remain active. In people with low food and fluid intake, those bedridden or at risk of bowel obstruction, fiber and fiber-containing drugs can worsen bloating and constipation. Determine appropriate fiber intake with your doctor in these situations.
- Will Laxatives Make My Bowel Lazy?
- Current evidence does not show permanent bowel damage from modern laxatives used as recommended. Leaving constipation untreated in cancer patients can cause much greater problems.
- Should I Stop Laxatives If I Develop Diarrhea?
- If stools become watery (Bristol type 6-7), the dose may need reducing or treatment pausing for a day. However, watery stool leaking around an impaction may be mistaken for diarrhea; consult your doctor if there is abdominal pain and bloating.
- Do Herbal Teas or Home Remedies Work?
- Prunes and hot drinks may help some people. Herbal products can interact with cancer drugs; consult your doctor or pharmacist before use.
Glossary
- Laxative
- Medication facilitating bowel movements; commonly called a "purgative".
- Opioid
- A group of strong painkillers such as morphine, oxycodone and fentanyl.
- Osmotic laxative
- A drug softening stool by retaining water in the bowel (macrogol, lactulose, magnesium).
- Stimulant laxative
- A drug increasing movement by stimulating bowel muscles (senna, bisacodyl, sodium picosulfate).
- Bulk-forming laxative
- A fiber product that retains water and increases stool volume (psyllium).
- PAMORA
- A drug group blocking opioid effects only in the bowel without entering the brain.
- Fecal impaction
- Hardened stool accumulating in the rectum or large bowel that cannot be passed.
- Bristol stool scale
- A scale classifying stool shape from 1-7.
- Hypercalcemia
- High blood calcium; may cause constipation, thirst and confusion.
- Spinal cord compression
- Tumor pressure on the spinal cord; an emergency with leg weakness and loss of bladder and bowel control.
DROZDOGAN Academy Commentary
Constipation is among the most common yet most overlooked problems in oncology practice. Patients often do not mention it through embarrassment or because they consider it trivial; physicians may forget to ask.
⚡ Why it matters
Untreated constipation worsens pain, nausea and appetite loss; it can lead patients to stop painkillers, disrupt chemotherapy and require emergency care.
✅ Strengths
Prevention is simple and effective. Inexpensive, widely available and safe laxatives exist. Specific drugs have been developed for opioid-induced constipation.
⚠️ Limitations
Few large studies compare laxatives in cancer patients; most recommendations rely on expert opinion. Access to macrogol and PAMORA drugs in Türkiye is limited.
🩺 What to do in practice
- When starting an opioid painkiller, a laxative the same day should also be started.
- Your bowel movement days and consistency should be recorded; tell your doctor at every checkup.
- If your fluid intake is low or you are bedridden, bulk-forming drugs and liquid paraffin should be avoided.
- When blood counts are low, suppositories and enemas do not use these.
- With abdominal pain, vomiting, inability to pass gas or leg weakness, do not wait.
❓ Open questions
Which laxative combination is most effective for cancer patients? When will specific opioid constipation drugs become widely accessible in Türkiye? Could introducing bowel function scales into daily oncology practice enable earlier detection of constipation?
Our brief verdict: Constipation in cancer patients is a preventable, treatable problem rather than a side effect to endure. Laxatives should be routine with opioids; osmotic and stimulant laxatives are first choices. Recognizing warning signs can save lives.
- This article updates our website's "Constipation in Cancer Patients – Causes, Prevention and Treatment Methods" in September 2026. It draws on the ESMO 2018 constipation guideline, United States National Cancer Institute (NCI) and American Cancer Society (ACS) information, Rome IV criteria, ACG-AGA 2023 chronic constipation and AGA 2019 opioid-induced constipation guidelines, and medication information websites in Türkiye.
- Corrections to the Previous Version: Added "weekly" and Rome IV criteria to the definition. "Musil" was classified as an oily laxative; mucilage-containing products are bulk-forming laxatives, while liquid paraffin is a separate lubricant. The statement that saline laxatives "increase swallowing movements" was incorrect; they draw water into the bowel. Lactulose onset was updated to 2-3 days. The claim that "stimulant laxatives cause a lazy colon" was corrected using current evidence. Added that bulk-forming laxatives are not recommended for opioid constipation or low fluid intake, and the aspiration risk of liquid paraffin. General advice such as "breakfast cereals" and "walk for at least one hour" was adapted for cancer patients. The medical consultation threshold changed from "two days" to "3 days or longer", and emergency warning signs were added.
- Reported from secondary sources: ESMO and ACG-AGA recommendations were taken from summaries of guidelines and a press release; laxative safety assessment from a review; and the Bristol scale from a secondary source.
- Unverified: Market availability in Türkiye of macrogol licensed for constipation, drug products containing psyllium or liquid paraffin, magnesium laxatives, PAMORA drugs and oxycodone-naloxone combinations; prescription status of laxatives; current availability of prucalopride.
- Based on general knowledge: Constipation caused by calcium drugs and aluminum-containing stomach medicines, toilet posture, evening senna use, prunes, overflow mistaken for diarrhea, vincristine-related paralytic ileus, signs of spinal cord compression and high calcium, and warnings about suppositories and rectal thermometers are presented as established medical knowledge.
- The laxative table's "first choice" and "caution" labels, stepwise treatment and warning sign diagrams, and Academy commentary are our own.
- The diagrams derive from verified statements in the text; they contain no new data.
- This article is not personal medical advice. Consult your doctor about laxative choice and dosage.
References
- Larkin PJ et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv111-iv125.
- Rome Foundation. Rome IV criteria: functional constipation (C2) and opioid-induced constipation (C6).
- Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-924.
- National Cancer Institute. Gastrointestinal complications (PDQ®) – health professional version; Constipation and cancer treatment (patient page).
- American Cancer Society. Constipation (patient information page).
- Chang L et al. American Gastroenterological Association–American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation. 2023 (AGA press release).
- Crockett SD et al. American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019.
- Whorwell PJ, Lange R, Scarpignato C. Review of stimulant laxative safety. Ther Adv Gastroenterol. 2024.
- Medication information websites (ilacabak.com): product lists for lactulose, sennosides, bisacodyl, sodium picosulfate and enemas, September 2026.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.